EB43/R4 – Area for Intervention: Enabling access to monoclonal antibodies to treat and prevent infectious diseases in LMICs

EB43/R3 – Extension of term of the Unitaid Board Vice-Chair

EB43/R2 – Extension of term of the Unitaid Board Chair

EB43/R1 – Approval of revisions to the KPI framework

EB42/R7 – Scheduling of the 43rd Executive Board meeting

EB42/R6 – Unitaid Commitment Policy

EB42/R5 – Audited Financial Statements for 2022 and Report of the External Auditor

EB42/R4 – Renewal of the appointments of the Chair and appointment of the Vice Chair of the Proposal Review Committee